Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform

Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China

Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial

Immunic granted European patent for vidofludimus calcium dosing regimens

Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment

Pfizer reports positive Phase 2 results for trispecific antibody in atopic dermatitis

Kelun-Biotech and Harbour BioMed receive China IND approval for atopic dermatitis therapy

Melodia Therapeutics reports award of US patent covering MLD-151

GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline

Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH

Formosa Pharmaceuticals signs licensing deal with Arrotex for APP13007 in Australia and New Zealand

Merck and Mayo Clinic launch AI-driven drug discovery collaboration

Palisade Bio makes Clinical Advisory Board appointment

STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)